beta
CLBS
Caladrius Biosciences, Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes CLBS12, CLBS14, CLBS16, and CLBS03. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ.
Market Cap: 28.8 Million
Primary Exchange: NASDAQ
Website: http://www.caladrius.com
Shares Outstanding: 14.9 Million
Float: 14.4 Million
Dividend: (%)
Beta: 0.202369083375244
Sector: Distribution Services
Industry: Wholesale Distributors
Ethical Flags
Longest drawdown: 1807 trading days
From: 2013-09-19 To: 2020-06-02
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|---|---|---|---|---|---|
| 2016-07-28 | 10.0 | 1.0 | 10.0 | |||
| 2013-07-16 | 10.0 | 1.0 | 10.0 |